5 Best Healthcare Stocks Under $20 According to Michael Castor’s Sio Capital

In this article, we discuss the 5 best healthcare stocks under $20 according to Michael Castor’s Sio Capital. If you want to see our detailed analysis of Castor’s history, investment philosophy, and hedge fund performance, go directly to 10 Best Healthcare Stocks Under $20 According to Michael Castor’s Sio Capital.

5. Affimed N.V (NASDAQ:AFMD)

Castor’s Stake Value: $6.07 million

Percentage of Michael Castor’s 13F Portfolio: 1.51%

Number of Hedge Fund Holders: 25

Stock Price as of September 23: $6.26

Affimed N.V. (NASDAQ:AFMD) is a clinical-stage biopharmaceutical company that focuses on the discovery and development of immunotherapies for the treatment of cancer. Ranked fifth on our list of the 10 best healthcare stocks under $20 according to Michael Castor’s Sio Capital, Affimed N.V (NASDAQ:AFMD) has a market capitalization of $749.52 million.

Michael Castor’s Sio Capital Management currently holds 714,576 shares of Affimed N.V (NASDAQ:AFMD), amounting to over $6.07 million in worth and accounting for 1.51% of the fund’s portfolio. By the end of the second quarter of 2021, 25 hedge funds out of the 873 tracked by Insider Monkey held stakes in Affimed N.V (NASDAQ:AFMD) worth roughly $240.7 million. This is compared to 23 hedge funds in the previous quarter with a total stake value of approximately $262 million.

On September 8, Affimed N.V (NASDAQ:AFMD) issued its quarterly earnings report for the second quarter of 2021, with reported earnings per share at -$0.19, missing market estimates by $0.08. The company also reported revenues of $11.47 million, surpassing estimated revenues by $2.44 million.

On April 12, investment advisory BMO Capital maintained an Outperform rating on Affimed N.V. (NASDAQ:AFMD) stock and raised the price target to $15 from $12, highlighting positive results regarding the drugs being developed by the company.